We already have the reimbursement code, so what he said there isn't quite true?
And IF we get to the 1000 per quarter at approx $600 per test, that is a decent start to our revenue given its just one of our tests.
Endo should be soon in Australia. D should be in the US this quarter.
The MD is doing the rounds of presentations. The market still not coming to the party.
Milesy
Ann: Investor Presentation - JMM Biotech Forum, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $62.19M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.0¢ | 36.0¢ | $53.71K | 143.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 491 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 39195 | 2 |
View Market Depth
| Last trade - 15.55pm 07/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |